Evaxion A (EVAX) Free Cash Flow (2020 - 2022)
Evaxion A (EVAX) reported Free Cash Flow of -$5.1 million for Q2 2022, up 52.41% on a YoY basis from -$3.4 million in Q2 2021, and up 36.2% quarter-over-quarter from -$8.0 million in Q1 2022.
Evaxion A (EVAX) Free Cash Flow (2020 - 2022) Analysis & Trends
Evaxion A has reported Free Cash Flow for 3 years, with the latest figure at -$5.1 million in Q2 2022.
- For the quarter ending Q2 2022, Free Cash Flow rose 52.41% year-over-year to -$5.1 million; the trailing twelve-month figure through Mar 2023 stood at -$5.1 million (up 85.59% YoY), and the FY2025 full-year result was -$6.6 million, up 49.49% from the prior year.
- Free Cash Flow for Q2 2022 stood at -$5.1 million, up from -$8.0 million in the prior quarter.
- The five-year high for Free Cash Flow was -$2.9 million in Q1 2020, with the low at -$16.7 million in Q3 2021.
- Historically, Free Cash Flow has averaged -$7.5 million across 3 years, with a median of -$6.6 million in 2020.
- The largest YoY upside for Free Cash Flow was 52.41% in 2022 against a maximum downside of 113.3% in 2022.
- Evaxion A's Free Cash Flow stood at -$7.9 million in 2020, then slumped by 110.2% to -$16.7 million in 2021, then soared by 69.41% to -$5.1 million in 2022.
- The last three Free Cash Flow figures came in at -$5.1 million (Q2 2022), -$8.0 million (Q1 2022), and -$16.7 million (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 848.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -5.11 Mn |
| Jun 30, 2022 | -5.11 Mn |
| Mar 31, 2022 | -8.01 Mn |
| Mar 31, 2022 | -8.01 Mn |
| Sep 30, 2021 | -16.69 Mn |
| Sep 30, 2021 | -16.69 Mn |
| Jun 30, 2021 | -10.73 Mn |
| Jun 30, 2021 | -10.73 Mn |
| Mar 31, 2021 | -3.75 Mn |
| Mar 31, 2021 | -3.75 Mn |
| Sep 30, 2020 | -7.94 Mn |
| Sep 30, 2020 | -7.94 Mn |
| Jun 30, 2020 | -5.18 Mn |
| Jun 30, 2020 | -5.18 Mn |
| Mar 31, 2020 | -2.89 Mn |
| Mar 31, 2020 | -2.89 Mn |